Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Texxon Holding Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
Revenue
553
673
797
Cost of revenue
549
668
792
Gross profit
3.53
4.82
4.7
Selling and marketing
1
1.99
2.41
General and administrative
1.28
2.17
2.89
Operating expenses
2.28
4.16
5.3
Operating income
1.25
0.66
-0.6
Interest income
0.59
0.03
Other non-operating income
0.88
2.57
-0.14
Pre-tax income
2.13
3.23
-0.74
Income tax
0.04
0.72
0.72
Net income to minority interests
0.07
1.56
-0.52
Net income
2.02
0.95
-0.93
EBITDA
1.51
0.99
-0.31
EPS, basic
0.10
0.05
-0.05
EPS, diluted
0.10
0.05
-0.05
Shares, basic (weighted)
20
20
20
Shares, diluted (weighted)
20
20
20
Balance sheet
FY2023
FY2025
FY2025
Cash and equivalents
1.33
0.27
2.52
Receivables
11.1
7.52
Inventory
0.87
0.97
Other current assets
1.35
6.92
Total current assets
18
20.8
Property, plant and equipment
23.4
84.6
Intangible assets
6.21
6.16
Total assets
74.9
89.7
139
Accounts payable
1.29
0.76
Deferred revenue
0.64
2.27
Short-term debt
25.8
20.6
Total current liabilities
57.3
72.7
Long-term debt
32.2
Total liabilities
57.3
105
Total debt
25.8
52.8
Paid-in capital
0.78
0.78
Retained earnings
-3.38
-4.32
Other comprehensive income
-0.25
-0.28
Shareholders' equity
-2.85
-3.81
Minority interests
35.2
37.9
Total equity
33.1
32.4
34
Total liabilities and equity
89.7
139
Shares outstanding
20
20
Cash flow statement
FY2023
FY2025
FY2025
Net income
2.09
2.51
-1.45
Depreciation and amortization
0.25
0.33
0.29
Change in receivables
3.71
-7.51
2.99
Change in inventory
-0.36
-0.47
-0.09
Cash from operations
-14.2
-30.8
2.32
Capital expenditures
-22.6
-33.3
-45.1
Cash from investing
-41.2
-11
-42.2
Cash from financing
30.4
29.4
41.4
Exchange rate effect
-1.56
1.33
0.02
Net change in cash
-26.6
-11.1
1.46
Free cash flow
-36.8
-64.1
-42.8
Interest paid
0.36
0.55
1.94
Income taxes paid
0
0
0.01
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.87 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
0.6%
Gross profit / revenue.
Operating margin
-0.1%
Operating income / revenue.
EBITDA margin
-0.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-0.1%
Pre-tax income / revenue.
Net margin
-0.1%
Net income / revenue.
FCF margin
-5.4%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
0.3%
Cash from operations / revenue.
Return on assets (ROA)
-0.8%
Net income / average total assets.
Return on invested capital (ROIC)
-1.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue
5.7%
Capital expenditures / revenue.
D&A / revenue
0.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
18.5%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-2.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
-191.0%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-131.5%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-197.8%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-200.0%
EPS vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
54.9%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.29x
Current assets / current liabilities.
Quick ratio
0.14x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.03x
(Cash + short-term investments) / current liabilities.
Debt / assets
38.0%
Total debt / total assets.
Liabilities / assets
75.5%
Total liabilities / total assets.
Net debt
$50.3M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
1,940.0%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.05
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.05
Net income per basic share, as reported (split-adjusted).
Revenue per share
$39.86
Revenue / diluted weighted shares.
FCF per share
-$2.14
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.12
Cash from operations / diluted weighted shares.
Book value per share
-$0.19
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.08x
Market cap / revenue.
P/OCF
27.4x
Market cap / cash from operations, when positive.
EV/Sales
0.14x
Enterprise value / revenue.
FCF yield
-67.2%
Free cash flow / market cap.
Earnings yield
-1.5%
Net income / market cap (the inverse of P/E).
What was Texxon Holding Ltd's revenue in fiscal 2025?
Texxon Holding Ltd reported revenue of $797.1M for fiscal 2025, 18.5% higher than the year before.
Was Texxon Holding Ltd profitable in fiscal 2025?
No. It reported a net loss of $932.6K.
How much free cash flow did Texxon Holding Ltd generate in fiscal 2025?
Cash from operations of $2.3M minus capital expenditures of $45.1M left free cash flow of -$42.8M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.